Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chee M Ng

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Magnetic Resonance Imaging|December 4, 2012
GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumabYu-Han H Hsu, Gregory Z Ferl, Chee M Ng
Plos One|March 26, 2020
Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancerYixuan Zou, Fei Tang, Jeffery C Talbert, et al.
The AAPS Journal|April 15, 2016
Mechanism-Based Competitive Binding Model to Investigate the Effect of Neonatal Fc Receptor Binding Affinity on the Pharmacokinetic of Humanized Anti-VEGF Monoclonal IgG1 Antibody in Cynomolgus MonkeyChee M Ng, Paul J Fielder, Jin Jin, et al.
Clinical and Translational Science|March 2, 2021
Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatmentsFei Tang, Chee M Ng, Henrietta S Bada, et al.
Journal of Clinical Pharmacology|October 1, 2010
Synergy between scientific advancement and technological innovation, illustrated by a mechanism-based model characterizing sodium-glucose cotransporter-2 inhibitionLiping Zhang, Chee M Ng, James F List, et al.
Pharmaceutical Research|May 23, 2006
Rationale for fixed dosing of pertuzumab in cancer patients based on population pharmacokinetic analysisChee M Ng, Bert L Lum, Veronica Gimenez, et al.
Plos One|March 19, 2015
GPU-accelerated compartmental modeling analysis of DCE-MRI data from glioblastoma patients treated with bevacizumabYu-Han H Hsu, Ziyin Huang, Gregory Z Ferl, et al.
Clinical Pharmacology and Therapeutics|November 22, 2024
Pharmacokinetic Modeling and Model-Based Hypothesis Generation for Dose Optimization of Clonidine in Neonates With Neonatal Opioid Withdrawal SyndromeFei Tang, Chee M Ng, Jamie Horn, et al.
Journal of Clinical Pharmacology|November 6, 2014
Novel method to predict body weight in children based on age and morphological facial featuresZiyin Huang, Jeffrey S Barrett, Kyle Barrett, et al.
Investigational New Drugs|March 2, 2019
Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumorsFei Tang, Eleftheria Tsakalozou, Susanne M Arnold, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Magnetic Resonance Imaging|December 4, 2012
GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumabYu-Han H Hsu, Gregory Z Ferl, Chee M Ng
Plos One|March 26, 2020
Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancerYixuan Zou, Fei Tang, Jeffery C Talbert, et al.
The AAPS Journal|April 15, 2016
Mechanism-Based Competitive Binding Model to Investigate the Effect of Neonatal Fc Receptor Binding Affinity on the Pharmacokinetic of Humanized Anti-VEGF Monoclonal IgG1 Antibody in Cynomolgus MonkeyChee M Ng, Paul J Fielder, Jin Jin, et al.
Clinical and Translational Science|March 2, 2021
Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatmentsFei Tang, Chee M Ng, Henrietta S Bada, et al.
Journal of Clinical Pharmacology|October 1, 2010
Synergy between scientific advancement and technological innovation, illustrated by a mechanism-based model characterizing sodium-glucose cotransporter-2 inhibitionLiping Zhang, Chee M Ng, James F List, et al.
Pharmaceutical Research|May 23, 2006
Rationale for fixed dosing of pertuzumab in cancer patients based on population pharmacokinetic analysisChee M Ng, Bert L Lum, Veronica Gimenez, et al.
Plos One|March 19, 2015
GPU-accelerated compartmental modeling analysis of DCE-MRI data from glioblastoma patients treated with bevacizumabYu-Han H Hsu, Ziyin Huang, Gregory Z Ferl, et al.
Clinical Pharmacology and Therapeutics|November 22, 2024
Pharmacokinetic Modeling and Model-Based Hypothesis Generation for Dose Optimization of Clonidine in Neonates With Neonatal Opioid Withdrawal SyndromeFei Tang, Chee M Ng, Jamie Horn, et al.
Journal of Clinical Pharmacology|November 6, 2014
Novel method to predict body weight in children based on age and morphological facial featuresZiyin Huang, Jeffrey S Barrett, Kyle Barrett, et al.
Investigational New Drugs|March 2, 2019
Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumorsFei Tang, Eleftheria Tsakalozou, Susanne M Arnold, et al.
Pageof 4